These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1185 related articles for article (PubMed ID: 26868851)

  • 1. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
    Wang B; Sun F; Dong N; Sun Z; Diao Y; Zheng C; Sun J; Yang Y; Jiang D
    Diagn Pathol; 2014 Nov; 9():211. PubMed ID: 25394492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transcriptional coactivator TAZ in gliomas.
    Li W; Dong S; Wei W; Wang G; Zhang A; Pu P; Jia Z
    Oncotarget; 2016 Dec; 7(50):82686-82699. PubMed ID: 27764783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-144 represses gliomas progression and elevates susceptibility to Temozolomide by targeting CAV2 and FGF7.
    Liu ZQ; Ren JJ; Zhao JL; Zang J; Long QF; Du JJ; Jia XT; Gu NB; Di ZL; Qian YH; Li SZ
    Sci Rep; 2020 Mar; 10(1):4155. PubMed ID: 32139705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
    Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q
    Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.
    Yang TQ; Lu XJ; Wu TF; Ding DD; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Guo LC; Zhang Y; Huang YL; Zhou YX; Du ZW
    Cancer Sci; 2014 Mar; 105(3):265-71. PubMed ID: 24418124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
    Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
    Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased Expression of MiRNA-204-5p Contributes to Glioma Progression and Promotes Glioma Cell Growth, Migration and Invasion.
    Xia Z; Liu F; Zhang J; Liu L
    PLoS One; 2015; 10(7):e0132399. PubMed ID: 26134825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-372 regulates glioma cell proliferation and invasion by directly targeting PHLPP2.
    Chen X; Hao B; Han G; Liu Y; Dai D; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
    J Cell Biochem; 2015 Feb; 116(2):225-32. PubMed ID: 25160587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-221/222 promote malignant progression of glioma through activation of the Akt pathway.
    Zhang J; Han L; Ge Y; Zhou X; Zhang A; Zhang C; Zhong Y; You Y; Pu P; Kang C
    Int J Oncol; 2010 Apr; 36(4):913-20. PubMed ID: 20198336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans.
    Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H
    Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor.
    He Z; Cen D; Luo X; Li D; Li P; Liang L; Meng Z
    Med Oncol; 2013; 30(2):557. PubMed ID: 23564324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells.
    Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW
    Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
    Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
    Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
    Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
    Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1.
    Li Y; Wang X; Zhao Z; Shang J; Li G; Zhang R
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 33393590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.
    Li S; Zeng A; Hu Q; Yan W; Liu Y; You Y
    Neuro Oncol; 2017 Jan; 19(1):55-65. PubMed ID: 27471108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.